Initiated in 1975, the Eberbach/Wiesloch Study is a prospective
preventive study modeled after the Cardiovascular Comprehensive
Community Central Programme of the WHO, with the aim of lowering the
incidence of cardiac infarctions in a population representative of that
of the Federal Republic of Germany. Part of the study is devoted to a
description of smoking habits, and in particular, of the effect of
cigarette smoking on plasma lipid and lipoprotein levels. Important
components of this investigation were the inclusion of plasma levels of
cotinine (a stable metabolite of nicotine and the only precise parameter
of cigarette consumption), as well as the correlation of cotinine with
other plasma parameters. Not only are these studies unique in the
Federal Republic of Germany, but they also provide significant insight
into the development of arteriosclerosis in connection with the
established risk factors of smoking and hyperlipidemia. The data
collected point to a considerable influence of smoking behavior on
plasma lipid protein parameters.